WuXi Biologics (Cayman) Inc. (WXXWY)

WuXi Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	19,617	9,282	16,000	32,432	50,135	54,159
Market Cap Growth	71.07%	-41.99%	-50.67%	-35.31%	-7.43%	230.33%
Enterprise Value	19,151	9,147	15,717	31,764	48,751	53,941
Last Close Price	9.39	4.43	7.45	15.07	23.44	26.31
PE Ratio	33.49	20.19	33.37	50.61	93.99	209.36
PS Ratio	7.01	3.63	6.66	14.65	30.95	63.00
PB Ratio	2.86	1.49	2.58	6.18	9.74	16.92
P/TBV Ratio	3.27	1.70	2.96	6.79	10.56	17.69
P/FCF Ratio	79.88	52.62	182.37	-	-	-
P/OCF Ratio	24.56	12.99	24.31	40.37	92.82	187.95
EV/Sales Ratio	6.80	3.58	6.54	14.35	30.10	62.75
EV/EBITDA Ratio	19.60	11.42	22.61	43.22	85.50	198.82
EV/EBIT Ratio	24.84	14.56	28.34	50.36	97.69	234.41
EV/FCF Ratio	77.99	51.85	179.13	-	-	-
Debt / Equity Ratio	0.10	0.11	0.10	0.12	0.13	0.16
Debt / EBITDA Ratio	0.73	0.82	0.89	0.86	1.18	1.85
Debt / FCF Ratio	2.90	3.84	7.33	-	-	-
Net Debt / Equity Ratio	-0.15	-0.13	-0.15	-0.12	-0.21	-0.25
Net Debt / EBITDA Ratio	-1.09	-0.99	-1.36	-0.85	-1.89	-2.91
Net Debt / FCF Ratio	-4.22	-4.48	-10.74	13.14	2.22	1.24
Asset Turnover	0.34	0.33	0.32	0.33	0.28	0.24
Inventory Turnover	6.36	6.71	5.04	4.31	3.94	4.15
Quick Ratio	2.40	1.98	2.35	1.56	1.85	2.49
Current Ratio	2.88	2.73	2.78	1.98	2.37	3.16
Return on Equity (ROE)	10.51%	8.82%	8.90%	13.20%	13.09%	10.02%
Return on Assets (ROA)	5.89%	5.05%	4.63%	5.81%	5.43%	4.03%
Return on Invested Capital (ROIC)	10.55%	9.71%	9.72%	12.78%	13.38%	10.74%
Return on Capital Employed (ROCE)	10.60%	9.50%	8.00%	10.80%	8.90%	6.10%
Earnings Yield	2.99%	4.95%	3.00%	1.98%	1.06%	0.48%
FCF Yield	1.25%	1.90%	0.55%	-0.15%	-0.97%	-1.17%
Buyback Yield / Dilution	2.55%	2.80%	0.62%	1.04%	-5.05%	-5.30%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.